S.Korea signs with Pfizer for extra 40 mln Covid-19 vaccine doses
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
South Korea said on Saturday it signed a contract with Pfizer Inc (PFE.N) to purchase an additional 40 million doses of its Covid-19 vaccine amid fears of spiking infections at home.
That brings the current amount of Pfizer vaccines to 66 million doses, it said in a statement.
It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc (MRNA.O), AstraZeneca PLC (AZN.L), Johnson & Johnson's (JNJ.N) and Novavax (NVAX.O).
Keep updated, follow The Business Standard's Google news channel
